| Dr Sam Fuller, MD | |
|
53880 Carmichael Dr, South Bend, IN 46635-1567 | |
| (574) 247-9441 | |
| (574) 247-9442 |
| Full Name | Dr Sam Fuller |
|---|---|
| Gender | Male |
| Speciality | Hand Surgery |
| Experience | 15 Years |
| Location | 53880 Carmichael Dr, South Bend, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649569484 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | 01075560A (Indiana) | Primary |
| 2086S0105X | Surgery - Surgery Of The Hand | 01075560A (Indiana) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Joseph Regional Medical Center - Plymouth | Plymouth, IN | Hospital |
| Saint Joseph Regional Medical Center | Mishawaka, IN | Hospital |
| Memorial Hospital Of South Bend | South bend, IN | Hospital |
| La Porte Hospital | La porte, IN | Hospital |
| Lakeland Hospital, St Joseph | St joseph, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascendant Orthopedic Alliance Llc | 7618234121 | 58 |
| Central Indiana Orthopedics Llc | 5698667822 | 142 |
News Archive
New knee-scanning procedures developed by Australia's Monash University will provide more accurate diagnosis methods for doctors and save patients time and money.
Merck & Co., Inc. has announced that David E. Kelley, M.D., has been named vice president, franchise integrator for Diabetes & Obesity. Dr. Kelley joins Merck after 20 years on staff at the University of Pittsburgh, where he most recently served as professor of medicine and director of the Obesity & Nutrition Research Center.
On March 16, 2010, DARA BioSciences, Inc. received notice from the Listing Qualifications Staff of The NASDAQ Stock Market LLC indicating that the Company had not timely regained compliance with the $1.00 bid price requirement, as set forth in Listing Rule 5550(a)(2). DARA plans to timely request a hearing before a NASDAQ Listing Qualifications Panel, at which it will request the continued listing of its securities on The NASDAQ Capital Market pending the completion of its plan to evidence compliance with the minimum bid price requirement.
Stem cells hold great promise for the medicine of the future, but they can also be a cause of disease. When these self-renewing, unspecialized cells fail to differentiate into diverse cell types, they can start dividing uncontrollably, leading to cancer. Already several decades ago, Weizmann Institute scientists were among the first to demonstrate the link between cancer and the faulty differentiation of stem cells. Now a new Weizmann Institute-led study, published in Molecular Cell, reveals a potential molecular mechanism behind this link.
› Verified 2 days ago
| Entity Name | Central Indiana Orthopedics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063422137 PECOS PAC ID: 5698667822 Enrollment ID: O20040325000156 |
News Archive
New knee-scanning procedures developed by Australia's Monash University will provide more accurate diagnosis methods for doctors and save patients time and money.
Merck & Co., Inc. has announced that David E. Kelley, M.D., has been named vice president, franchise integrator for Diabetes & Obesity. Dr. Kelley joins Merck after 20 years on staff at the University of Pittsburgh, where he most recently served as professor of medicine and director of the Obesity & Nutrition Research Center.
On March 16, 2010, DARA BioSciences, Inc. received notice from the Listing Qualifications Staff of The NASDAQ Stock Market LLC indicating that the Company had not timely regained compliance with the $1.00 bid price requirement, as set forth in Listing Rule 5550(a)(2). DARA plans to timely request a hearing before a NASDAQ Listing Qualifications Panel, at which it will request the continued listing of its securities on The NASDAQ Capital Market pending the completion of its plan to evidence compliance with the minimum bid price requirement.
Stem cells hold great promise for the medicine of the future, but they can also be a cause of disease. When these self-renewing, unspecialized cells fail to differentiate into diverse cell types, they can start dividing uncontrollably, leading to cancer. Already several decades ago, Weizmann Institute scientists were among the first to demonstrate the link between cancer and the faulty differentiation of stem cells. Now a new Weizmann Institute-led study, published in Molecular Cell, reveals a potential molecular mechanism behind this link.
› Verified 2 days ago
| Entity Name | Ascendant Orthopedic Alliance Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336665991 PECOS PAC ID: 7618234121 Enrollment ID: O20171207001962 |
News Archive
New knee-scanning procedures developed by Australia's Monash University will provide more accurate diagnosis methods for doctors and save patients time and money.
Merck & Co., Inc. has announced that David E. Kelley, M.D., has been named vice president, franchise integrator for Diabetes & Obesity. Dr. Kelley joins Merck after 20 years on staff at the University of Pittsburgh, where he most recently served as professor of medicine and director of the Obesity & Nutrition Research Center.
On March 16, 2010, DARA BioSciences, Inc. received notice from the Listing Qualifications Staff of The NASDAQ Stock Market LLC indicating that the Company had not timely regained compliance with the $1.00 bid price requirement, as set forth in Listing Rule 5550(a)(2). DARA plans to timely request a hearing before a NASDAQ Listing Qualifications Panel, at which it will request the continued listing of its securities on The NASDAQ Capital Market pending the completion of its plan to evidence compliance with the minimum bid price requirement.
Stem cells hold great promise for the medicine of the future, but they can also be a cause of disease. When these self-renewing, unspecialized cells fail to differentiate into diverse cell types, they can start dividing uncontrollably, leading to cancer. Already several decades ago, Weizmann Institute scientists were among the first to demonstrate the link between cancer and the faulty differentiation of stem cells. Now a new Weizmann Institute-led study, published in Molecular Cell, reveals a potential molecular mechanism behind this link.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sam Fuller, MD 3600 W Bethel Ave, Muncie, IN 47304-5407 Ph: () - | Dr Sam Fuller, MD 53880 Carmichael Dr, South Bend, IN 46635-1567 Ph: (574) 247-9441 |
News Archive
New knee-scanning procedures developed by Australia's Monash University will provide more accurate diagnosis methods for doctors and save patients time and money.
Merck & Co., Inc. has announced that David E. Kelley, M.D., has been named vice president, franchise integrator for Diabetes & Obesity. Dr. Kelley joins Merck after 20 years on staff at the University of Pittsburgh, where he most recently served as professor of medicine and director of the Obesity & Nutrition Research Center.
On March 16, 2010, DARA BioSciences, Inc. received notice from the Listing Qualifications Staff of The NASDAQ Stock Market LLC indicating that the Company had not timely regained compliance with the $1.00 bid price requirement, as set forth in Listing Rule 5550(a)(2). DARA plans to timely request a hearing before a NASDAQ Listing Qualifications Panel, at which it will request the continued listing of its securities on The NASDAQ Capital Market pending the completion of its plan to evidence compliance with the minimum bid price requirement.
Stem cells hold great promise for the medicine of the future, but they can also be a cause of disease. When these self-renewing, unspecialized cells fail to differentiate into diverse cell types, they can start dividing uncontrollably, leading to cancer. Already several decades ago, Weizmann Institute scientists were among the first to demonstrate the link between cancer and the faulty differentiation of stem cells. Now a new Weizmann Institute-led study, published in Molecular Cell, reveals a potential molecular mechanism behind this link.
› Verified 2 days ago
Marie E Unruh, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Navarre Pl Ste 5500, South Bend, IN 46601 Phone: 574-647-5200 Fax: 574-647-5210 | |
Dr. Robert G. Credi, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 621 Memorial Dr Ste 502, South Bend, IN 46601 Phone: 574-647-5875 Fax: 574-647-5878 | |
Scott G Thomas, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 621 Memorial Dr, Suite 502, South Bend, IN 46601 Phone: 574-647-5875 Fax: 574-647-5878 | |
Michael C Rotkis, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 621 Memorial Dr, South Bend, IN 46601 Phone: 574-236-1888 Fax: 574-236-1887 | |
William Anderson, MD Surgery Medicare: Medicare Enrolled Practice Location: 621 Memorial Dr, Ste 502, South Bend, IN 46601 Phone: 574-647-5875 Fax: 515-643-5802 | |
George B Friend, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 621 Memorial Dr, South Bend, IN 46601 Phone: 574-236-1888 Fax: 574-236-1888 | |
Daniel P. Srikureja, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 621 Memorial Dr Ste 502, South Bend, IN 46601 Phone: 574-647-5875 Fax: 574-647-5878 |